. "On August 1, 2013, we entered into an agreement to initially license and, with an additional payment, fully acquire from 3M Company certain intellectual property and assets relating to 3M???s Taper Dry Powder Inhaler, or DPI, technology under development for the treatment of asthma and COPD. The intellectual property includes patents, patent applications and other intellectual property relating to" . . . .